Linifanib
Linifanib orally bioavailable, small-molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Reference standards of Linifanib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Linifanib - API Standards
[catalogue_number] => PA 65 28000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[weight] => 375.41
[form] => C21H18FN5O
[cas] => 796967-16-3
[pslug] => 796967-16-3-linifanib-api-pa6528000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Linifanib - API Standards
Catalogue No.:PA 65 28000
Molecular Formula : C21H18FN5O
Molecular Weight : 375.41